Andreas Maercker1. 1. Department of Psychology, Division Psychopathology and Clinical Intervention, University of Zurich, Binzmühlestr. 14/17, 8044, Zurich, Switzerland. maercker@psychologie.uzh.ch.
Abstract
BACKGROUND: The diagnosis of complex post-traumatic stress disorder (CPTSD) was proposed several decades ago by scientist-practitioners, almost parallel to the first description of the diagnosis of post-traumatic stress disorder (PTSD). In the previous International Classification of Diseases, version 10 (ICD-10) issued by the World Health Organization (WHO), this symptom constellation was termed 'enduring personality change after catastrophic experience'. This diagnosis has not been clinically influential, nor has it been subjected to much research. Thus, in a multi-stage process of ICD-11 development, the diagnosis of CPTSD was developed. METHODS: This paper provides a review of the historical lines of development that led to the CPTSD diagnosis, as well as the results since the ICD-11 publication in 2018. RESULTS: The CPTSD diagnosis comprises the core symptoms of the - newly, narrowly defined - PTSD diagnosis, the three symptom groups of affective, relationship, and self-concept changes. The diagnosis is clinically easy to use in accordance with the WHO development goals for the ICD-11 and has shown good psychodiagnostic properties in various studies, including good discrimination from personality disorder with borderline pattern. CONCLUSION: The scholarly use of the new diagnosis has resulted in an increasing number of published studies on this topic in the diagnostic and therapeutic fields.
BACKGROUND: The diagnosis of complex post-traumatic stress disorder (CPTSD) was proposed several decades ago by scientist-practitioners, almost parallel to the first description of the diagnosis of post-traumatic stress disorder (PTSD). In the previous International Classification of Diseases, version 10 (ICD-10) issued by the World Health Organization (WHO), this symptom constellation was termed 'enduring personality change after catastrophic experience'. This diagnosis has not been clinically influential, nor has it been subjected to much research. Thus, in a multi-stage process of ICD-11 development, the diagnosis of CPTSD was developed. METHODS: This paper provides a review of the historical lines of development that led to the CPTSD diagnosis, as well as the results since the ICD-11 publication in 2018. RESULTS: The CPTSD diagnosis comprises the core symptoms of the - newly, narrowly defined - PTSD diagnosis, the three symptom groups of affective, relationship, and self-concept changes. The diagnosis is clinically easy to use in accordance with the WHO development goals for the ICD-11 and has shown good psychodiagnostic properties in various studies, including good discrimination from personality disorder with borderline pattern. CONCLUSION: The scholarly use of the new diagnosis has resulted in an increasing number of published studies on this topic in the diagnostic and therapeutic fields.
Authors: Patricia A Resick; Michelle J Bovin; Amber L Calloway; Alexandra M Dick; Matthew W King; Karen S Mitchell; Michael K Suvak; Stephanie Y Wells; Shannon Wiltsey Stirman; Erika J Wolf Journal: J Trauma Stress Date: 2012-06
Authors: Geoffrey M Reed; Pratap Sharan; Tahilia J Rebello; Jared W Keeley; María Elena Medina-Mora; Oye Gureje; José Luis Ayuso-Mateos; Shigenobu Kanba; Brigitte Khoury; Cary S Kogan; Valery N Krasnov; Mario Maj; Jair de Jesus Mari; Dan J Stein; Min Zhao; Tsuyoshi Akiyama; Howard F Andrews; Elson Asevedo; Majda Cheour; Tecelli Domínguez-Martínez; Joseph El-Khoury; Andrea Fiorillo; Jean Grenier; Nitin Gupta; Lola Kola; Maya Kulygina; Itziar Leal-Leturia; Mario Luciano; Bulumko Lusu; J Nicolas; I Martínez-López; Chihiro Matsumoto; Lucky Umukoro Onofa; Sabrina Paterniti; Shivani Purnima; Rebeca Robles; Manoj K Sahu; Goodman Sibeko; Na Zhong; Michael B First; Wolfgang Gaebel; Anne M Lovell; Toshimasa Maruta; Michael C Roberts; Kathleen M Pike Journal: World Psychiatry Date: 2018-06 Impact factor: 49.548
Authors: Andreas Maercker; Chris R Brewin; Richard A Bryant; Marylene Cloitre; Geoffrey M Reed; Mark van Ommeren; Asma Humayun; Lynne M Jones; Ashraf Kagee; Augusto E Llosa; Cécile Rousseau; Daya J Somasundaram; Renato Souza; Yuriko Suzuki; Inka Weissbecker; Simon C Wessely; Michael B First; Shekhar Saxena Journal: Lancet Date: 2013-04-11 Impact factor: 79.321
Authors: Jared W Keeley; Geoffrey M Reed; Michael C Roberts; Spencer C Evans; Rebeca Robles; Chihiro Matsumoto; Chris R Brewin; Marylène Cloitre; Axel Perkonigg; Cécile Rousseau; Oye Gureje; Anne M Lovell; Pratap Sharan; Andreas Maercker Journal: Int J Clin Health Psychol Date: 2015-11-06
Authors: Joseph A Boscarino; Richard E Adams; Tiah J Wingate; Joseph J Boscarino; Thomas G Urosevich; Stuart N Hoffman; H Lester Kirchner; Charles R Figley; William P Nash Journal: Front Psychiatry Date: 2022-06-06 Impact factor: 5.435
Authors: Odeta Gelezelyte; Monika Kvedaraite; Agniete Kairyte; Neil P Roberts; Jonathan I Bisson; Evaldas Kazlauskas Journal: Borderline Personal Disord Emot Dysregul Date: 2022-04-12